Svetlana N. Chebysheva

Svetlana N. Chebysheva

Auto-generated profile, based on publicly available information

Svetlana N. Chebysheva

Sechenov First Moscow State Medical University (Sechenov University)

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 September 2020 in Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics)
Verified
Journal Article
Open access
PDF file
OGOleg Glazachev
Oleg Glazachev
NGNatalia Geppe
Natalia Geppe
YTYu. S. Timofeev
Yu. S. Timofeev
VSV. G. Samartseva
V. G. Samartseva
EDE. N. Dudnik
E. N. Dudnik
SCS. N. Chebysheva
S. N. Chebysheva
Индикаторы индивидуальной устойчивости к гипоксии — путь оптимизации применения гипоксических тренировок у детей

1 January 2020 in Doctor.Ru
Verified
Journal Article
Open access
SCS.N. Chebysheva
S.N. Chebysheva
RMRussian Federation Moscow
Russian Federation Moscow
NGNatalia Geppe
Natalia Geppe
EZElena Zholobova
Elena Zholobova
KAK.V. Aleksanyan
K.V. Aleksanyan
DDD.V. Dagbaeva
D.V. Dagbaeva
Study Objective: to present literature review of clinical parameters and course of psoriatic arthritis (PsA) in children, and results of PsA patients examination in University Clinical Children Hospital of I.M. Sechenov First Moscow State Medical University. Study Design: open prospective study. Materials and Methods. We analysed medical records of 83 children with PsA aged 3 to 17 years who were examined and managed in University Clinical Children Hospital of I.M. Sechenov First Moscow State Medical University in 1989 – 2019. Study Results. Confirmed PsA was diagnosed in 59 (71%) children, suspected PsA — in 24 (29%) children; 44 (53%) children got ill before they were 6.5 years old. In 24 (29%) patients, disease started with skin involvement; in 59 (71%) patients, articular syndrome was the first manifestation of disease. In the group of patients with confirmed psoriasis, the most common was plaque psoriasis: it was diagnosed in 45 (76.3%) out of 59 children; guttate psoriasis was found in 8 (13.5%) children, isolated nail plaque psoriasis — in 3 (5.1%) patients, and palm and foot psoriasis — in 3 (5.1%) children. Psoriasis of the scalp was diagnosed in 23 (39%) subjects. In 8 (13.5%) patients, skin syndrome was associated with mild infiltration and scant desquamation. 18 (21.7%) out of 83 children had skin involvement together with nail bed involvement. Psoriasic onychodystrophy was diagnosed in 19 (23%) children (onycholysis, “oil patches” on fingers and toes); 15 (18.1%) children had “thimble syndrome”. On disease onset, 68.7% of children had oligoarticular, sometimes asymmetric articular syndrome; 18.1% had symmetric rheumatoid-like disease, 13.2% — psoriasic spondylitis. After 5 years of follow-up, articular syndrome transformed: 41.2% of patients had symmetric rheumatoid-like disease, 24.1% — asymmetric oligoarthritis, 24.1% — spondylarthritis with peripheral joint involvement, and 10.8% — arthritis mutilans. Most commonly PsA affected knee, talocrural joints, small hand joints – 41%, 31.3%, 29%, respectively. Conclusion. Clinical manifestations of PsA varied a lot. Our patients did not have a second peak. Almost one third of children had skin changes prior to arthritis development. Onset of disease was associated with asymmetric oligoarthritis prevalence. Later, articular syndrome changed, and symmetric rheumatoid-like disease prevailed. Keywords: children, psoriatic arthritis, psoriasis, juvenile idiopathic arthritis, Vancouver diagnostic criteria.

4 April 2025 in Pediatrics. Consilium Medicum
Verified
Journal Article
Open access
PDF file
APAngelina V. Polyanskaya
Angelina V. Polyanskaya
SCSvetlana N. Chebysheva
Svetlana N. Chebysheva
EYEkaterina A. Yablokova
Ekaterina A. Yablokova
IKIrina Korsunskaya
Irina Korsunskaya
NGNatalia Geppe
Natalia Geppe
VKValeriia V. Kimutsadze
Valeriia V. Kimutsadze
Inflammatory bowel diseases (IBD) Crohn's disease (CD) and ulcerative colitis (UC) are a group of idiopathic abnormal bowel conditions with unclear etiology and similar clinical courses. In addition to intestinal syndrome, these diseases are often associated with extraintestinal manifestations, the most common of which is the involvement of the peripheral joints and axial skeleton. The increase in the incidence of IBD, especially CD, in childhood warrants further study of this condition's features, including the most common extraintestinal manifestation: joint involvement (JI) in pediatric patients with IBD. Aim. To analyze the features of JI in CD and UC and the timing of its occurrence associated with IBD onset. Materials and methods. We reviewed 146 case histories of patients aged 4 to 18 diagnosed with CD and UC treated in the Gastroenterological Department and Rheumatological Department No.1 of the Mother and Child Center of Sechenov University from 2017 to 2024. The diagnosis of CD and UC was established following the clinical guidelines of the Union of Pediatricians of Russia for diagnosing and treating CD (2021) and UC (2024) in children. A rheumatologist examined the joints and assessed the JI. The classification criteria of the Assessment of SpondyloArthritis International Society (ASAS, 2011) for predominantly peripheral spondyloarthritis and the Garmisch-Partenkirchen JAS Diagnostic Criteria (1987) were used to verify the cause of the joint involvement. Mean values and standard deviation (M±σ) were used to summarize and estimate demographic continuous variables. Absolute values and percentages were calculated for patients in each study group. Results. Of the 146 patients, 60 (41%) had a combination of JI and IBD. Sixty children aged 4 to 18 with IBD and JI were divided into three groups: 36 (60%) patients with CD, 19 (32%) with UC, and 5 (8%) children with undifferentiated colitis (UndC). The mean age of patients with CD was 14.06±0.5, with UC–13.6±0.3, and UndC–15.2±0.2 years. Among all 60 patients, JI manifested with peripheral arthritis (PA) in 25 (42%) subjects, spondyloarthritis (SpA) in 16 (27%) subjects, or only arthralgias without evident inflammatory changes in the joints in 19 (31%). The analysis of JI variants by groups in children with CD (n=36) showed PA in 15 (42%), SpA in 12 (33%), and isolated arthralgia in 9 (25%) patients. The prevalence of PA and arthralgia among boys and girls with CD was comparable (60 and 40% of PA, 56 and 44% of arthralgias, respectively); the prevalence of SpA in boys with CD was significantly higher: found in 11 (92%) boys. In the group of children with UC (n=19), a high prevalence of PA and isolated arthralgia was reported: 8 (42%) and 9 (47%) patients, respectively. SpA was diagnosed in 2 (11%) children with UC. Of the 60 children with JI and IBD, 30 (50%) developed the disease with joint involvement. CD onset was associated with JI significantly more often than UC onset: of 30 children with JI, 21 (70%) were first diagnosed with rheumatic joint disease, and then CD was detected during follow-up. The disease first manifested with joint involvement in 6 (20%) patients with UC and 3 (10%) with UndC. The time interval from the onset of JI to the onset of the intestinal syndrome (and/or IBD diagnosis) varied widely from 1 month to several years; in 1 patient, it was more than 8 years. In 8 (27%) patients, this time interval was 1 to 3 months; in 6 (20%) patients, the symptoms of the underlying disease appeared within 12 to 24 months from the joint involvement manifestation. The atypical onset and course of the disease make diagnosis challenging and require increased doctor attention to patient management. As an illustration, the article presents a clinical case of an atypical onset and course of CD associated with juvenile SpA.

1 January 2020 in Doctor.Ru
Verified
Journal Article
Open access
EDE.V. Dvoryankova
E.V. Dvoryankova
CSCentre for Theory of Physical and Chemical Problems in Pharmacology of the Russian Academy of Science
Centre for Theory of Physical and Chemical Problems in Pharmacology of the Russian Academy of Science
ZNZ.A. Nevozinskaya
Z.A. Nevozinskaya
OVO.V. Vaal
O.V. Vaal
MDM.I. Denieva
M.I. Denieva
RGRussian Federation National Dermatovenerologic Clinic; Grozny
Russian Federation National Dermatovenerologic Clinic; Grozny
Objective of the Review: to present updated data on psoriasis for clinical pediatricians. Key Points. The article presents updated epidemiological information on psoriasis prevalence in paediatric population; early onset of disease accounts for 70%. Risk factors include genetic predisposition, immune changes, infective agents; children may also have stress as a trigger; in teenagers, smoking can facilitate severe psoriasis. Clinical presentation in paediatric population has some distinctive features: in children, plaque psoriasis is less frequent than in adults. Still, psoriasis of the scalp is diagnosed in approx. 79% of children. Psoriasis therapy in children is limited, but it has much in common with psoriasis management in adults. Conclusion. As psoriasis is associated with multiple non-dermatologic conditions (hepatobiliary disorders, Grohn’s disease, cardiovascular diseases, etc.), early diagnosis facilitates more comprehensive examination of patients for comorbidities and early diagnostics. There are no standardised recommendations for psoriasis management in children. Therefore, paediatric patients require more attention not only from dermatologists, but from paediatricians and multidisciplinary paediatric teams. Keywords: psoriasis, clinical presentations of psoriasis in children.

15 May 2019 in Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics)
Verified
Journal Article
Open access
PDF file
LGL. A. Galstyan
L. A. Galstyan
EZElena Zholobova
Elena Zholobova
SCS. N. Chebysheva
S. N. Chebysheva
APAngelina Polyanskaya
Angelina Polyanskaya
VSV. A. Seraya
V. A. Seraya
OLO. Yu. Loskutova
O. Yu. Loskutova
Rheumatoid uveitis is a serious problem in rheumatology and ophthalmology due to the peculiarities of the disease – an undistinguished beginning, chronic course and a high incidence of disabling complications. The article analyzes various data on the development and nature of uveitis in children with juvenile idiopathic arthritis. The authors describe the analysis of the results of various studies of this disease. They consider the features and results of treatment of children with rheumatoid uveitis using genetically engineered biological drugs.

8 August 2022 in Meditsinskiy sovet = Medical Council
Verified
Journal Article
Open access
PDF file
VSVladimir Sobolev
Vladimir Sobolev
SCS. N. Chebysheva
S. N. Chebysheva
NGNatalia Geppe
Natalia Geppe
KKK. V. Katkova
K. V. Katkova
ASAnna Soboleva
Anna Soboleva
IKIrina Korsunskaya
Irina Korsunskaya
Introduction. Psoriatic disease is a heterogeneous inflammatory disease with different clinical manifestations, including plaque psoriasis and psoriatic arthritis. It has been shown that elevated levels of TNF-α are observed in both psoriatic arthritis and psoriasis. Studying the TNF-α gene expression pattern can help in the differential diagnosis between psoriatic arthritis and psoriasis.The objective is to study the TNF-α gene expression pattern in blood mononuclear cells of patients with psoriatic arthritis and psoriasis for possible differential diagnosis between these two diseases.Materials and methods. Mononuclear cells were isolated from the peripheral blood of 31 patients with plaque psoriasis, 45 patients with psoriatic arthritis and 20 healthy controls. The expression level of the TNF-α gene was analysed using a real-time PCR method.Results and discussion. As a result of the comparison, the expression level of TNF-α in patients with psoriatic arthritis was found to be 179 times higher than the expression level in healthy volunteers. The expression level of TNF-α in patients with psoriasis was also significantly (106 times) higher than the expression level in healthy people. We managed to identify a significant difference between patients with psoriatic arthritis and psoriasis.Conclusions. Patients with psoriasis in terms of TNF-α gene expression level in mononuclear cells are close to the condition of patients with psoriatic arthritis. A high level of TNF-α gene expression can become a marker of possible joint injury in patients with psoriasis and a signal to revise the therapeutic approach to a particular patient.